Timeline a Swiss Longevity Biotech Secures Pivotal Financing Round with Support from Strategic Global Industry Leaders including LOral and Nestl
Summary
Timeline, a consumer health biotech company at the forefront of developing innovative solutions for healthy aging and longevity, today announces that it raised CHF 56M (USD 66M) in an oversubscribed Series D financing round. View the full release here: https://www.businesswire.com/news/home/20240117576326/en/The financing round was led by BOLD (Business Opportunities for LOr\xe9al Development), LOr\xe9al Groupes strategic innovation venture capital fund, underscoring investors confidence in the companys proprietary technology, Mitopure\xae, to help people live healthier for longer. Optimal mitochondrial function is essential for maintaining cellular energy which supports muscle strength, cognition, immune resilience, skin vitality and other important benefits, offering a comprehensive approach to promoting healthspan.The support of these industry leaders and the funds raised will be used to build Timeline into a leading longevity consumer health brand by expanding the science, product categories, and markets across food, beauty and health sectors. said Patrick Aebischer, Co-Founder and Chairman of Timeline I want to thank LOr\xe9al, Nestl\xe9 and our longstanding investors for their commitment to longevity solutions rooted in the highest level of science.Longevity is about living healthier for longer and LOr\xe9al has been working for a decade to understand and anticipate what this could mean for beauty, said Barbara Lavernos, Deputy Chief Executive Officer and in charge of Research, Innovation and Technology, LOr\xe9al. "We have been an investor in Timeline since 2019 and continue to be very impressed with the team and stand behind the exponential potential that the Mitopure technology holds for nutrition to help people age better, said Anna Mohl, CEO of Nestl\xe9 Health Science Were excited to have LOr\xe9al join as an investor and strategic partner to bring this technology to new heights and extend its applications.Timeline (parent company Amazentis) is a pioneering Swiss health science company committed to revolutionizing the longevity industry with its groundbreaking, clinically proven, proprietary ingredient Mitopure\xae.